Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med. 2019 Jul 25;381(4):307-316. doi: 10.1056/NEJMoa1903765. Epub 2019 Jun 4.
N Engl J Med. 2019.
PMID: 31166679
Clinical Trial.